Provista Diagnostics to Present at Leerink Global Healthcare Conference
09 févr. 2015 09h00 HE
|
Provista Diagnostics, Inc.
New York, NY, Feb. 9, 2015 (GLOBE NEWSWIRE) -- NEW YORK, NY - February 9, 2015: Provista
Diagnostics, Inc., a privately-held molecular diagnostics company
focused on developing and...
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
07 juil. 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, July 7, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...
Provista Diagnostics Laboratory Receives Accreditation from College of American Pathologists (CAP)
26 juin 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, June 26, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
delivering precision medicine to the medical community to
fundamentally change the detection...
Provista Diagnostics Announces First Patient Enrolled in Prospective, Proof-of-Concept Study of its Protein Biomarker Blood Test to Assess the Presence of Breast Cancer
19 mai 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, May 19, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...
Provista Diagnostics Licenses Biomarker Technologies Developed at Arizona State University
25 oct. 2013 05h00 HE
|
Provista Diagnostics, Inc.
Scottsdale, Arizona, Oct. 25, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a leading molecular diagnostics
company focused on developing and commercializing proprietary
diagnostic, prognostic...
Provista Diagnostics Announces Licensure to Offer Out of State Clinical Laboratory Services for Samples Originating in Florida
07 mai 2013 12h00 HE
|
Provista Diagnostics, Inc.
Scottsdale, AZ, May 7, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a leading molecular diagnostics
company focused on developing and commercializing proprietary
diagnostic, prognostic and...
Provista Diagnostics Announces Results of Annual Shareholder Meeting
06 mai 2013 08h00 HE
|
Provista Diagnostics, Inc.
Scottsdale, AZ, May 6, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a leading molecular diagnostics
company focused on developing and commercializing proprietary
diagnostic, prognostic and...
Provista Diagnostics Announces the Closing of $6.0 Million Financing
16 avr. 2013 12h50 HE
|
Provista Diagnostics, Inc.
Scottsdale, April 16, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc. is pleased to
announce the closing of a $6.0 million private round of Series A
Preferred financing on April 10, 2013. As...
Provista Diagnostics Announces the Closing of Additional $2.5 Million Series A Preferred Financing
18 sept. 2012 05h00 HE
|
Provista Diagnostics, Inc.
Scottsdale, Arizona, Sept. 18, 2012 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a provider of oncology-based
diagnostic tests and clinical laboratory services to the
pharmaceutical and...